Nanjing Leads Biolabs Co., Ltd. Class H (HK:9887)
:9887
Comparison Results
Nanjing Leads Biolabs Co., Ltd. Class H
HK$92.00
HK$17.79B
-71.60
39.42%
3 Buy
0 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$12.70
HK$27.47B
-1.72
19.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$37.22
HK$145.98B
11.12
75.57%
12 Buy
1 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$58.40B
18.63
65.32%
4 Buy
0 Hold
0 Sell
Strong Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$23.28B
42.36
403.26%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:9887
Nanjing Leads Biolabs Co., Ltd. Class H
93.55
20.25
27.63%
HK:1548
Genscript Biotech
12.70
2.18
20.72%
HK:2269
Wuxi Biologics (Cayman)
37.22
16.02
75.57%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
21.26
8.67
68.82%
HK:1873
Viva Biotech Holdings
1.89
0.46
32.17%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
61.80
49.82
415.86%